Exchange
NYSE American
Every company in the roster listed on NYSE American.
Research
Compare financial metrics on this exchange
Research adds market cap, cash, runway and annualized R&D metrics with metric-specific sorting.
Views
2 of 2 companies
| Company | Pipeline | Most advanced | Next readout |
|---|---|---|---|
 Protalix BioTherapeutics, Inc.PLX · NYSE American | 2 assets: 1 approved, 1 Ph 2 | PRX-115Phase 2 · Severe Refractory Gout | Dec 2027PRX-115 · Phase 2 |
 Annovis Bio (NYSE American: ANVS)ANVS · NYSE American | 1 asset: 1 Ph 3 | BuntanetapPhase 3 · Alzheimer's DiseasePartial signal | Dec 2027Buntanetap · Phase 3 |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov).